IT8249401A0 - Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici - Google Patents

Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici

Info

Publication number
IT8249401A0
IT8249401A0 IT8249401A IT4940182A IT8249401A0 IT 8249401 A0 IT8249401 A0 IT 8249401A0 IT 8249401 A IT8249401 A IT 8249401A IT 4940182 A IT4940182 A IT 4940182A IT 8249401 A0 IT8249401 A0 IT 8249401A0
Authority
IT
Italy
Prior art keywords
analyte
determining
solution
immunological assays
immunological
Prior art date
Application number
IT8249401A
Other languages
English (en)
Other versions
IT1149111B (it
Inventor
Demetrios P Papahadjopoulos
Timothy D Heath
Original Assignee
Univ California A Berkeley Cal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California A Berkeley Cal filed Critical Univ California A Berkeley Cal
Publication of IT8249401A0 publication Critical patent/IT8249401A0/it
Application granted granted Critical
Publication of IT1149111B publication Critical patent/IT1149111B/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT49401/82A 1981-10-29 1982-10-29 Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici IT1149111B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/316,126 US4598051A (en) 1980-03-12 1981-10-29 Liposome conjugates and diagnostic methods therewith

Publications (2)

Publication Number Publication Date
IT8249401A0 true IT8249401A0 (it) 1982-10-29
IT1149111B IT1149111B (it) 1986-12-03

Family

ID=23227584

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49401/82A IT1149111B (it) 1981-10-29 1982-10-29 Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici

Country Status (6)

Country Link
US (1) US4598051A (it)
EP (1) EP0091958A4 (it)
JP (1) JPS58501819A (it)
CA (1) CA1198053A (it)
IT (1) IT1149111B (it)
WO (1) WO1983001571A1 (it)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4696907A (en) * 1980-07-18 1987-09-29 Science Research Center, Inc. Identification of reagins in the blood serum of allergen sensitized vertebrates
EP0103139B1 (en) * 1982-08-11 1990-01-03 Kabushiki Kaisha Toshiba Reagent composition for immunoassay and immunoassay using the same
US4636479A (en) * 1983-04-20 1987-01-13 Cooper-Lipotech, Inc. Enhanced agglutination method and kit
US4605630A (en) * 1983-07-27 1986-08-12 Cooper Lipotech Inc. Large-liposome agglutination reagent and method
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
LU85971A1 (fr) * 1985-06-25 1987-01-13 Oreal Nouveaux composes lipidiques amphiphiles, leur procede de preparation et leurs applications,notamnent en cosmetique et en dermopharmacie
US4752572A (en) * 1985-08-30 1988-06-21 Eastman Kodak Company Lipid vesicles containing labeled species and their analytical uses
US4752563A (en) * 1985-11-19 1988-06-21 Coulter Corporation Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody
US4962022A (en) * 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
KR900007831B1 (ko) * 1986-11-28 1990-10-20 더 리포조옴 캄파니, 인코포레이티드 인지질 조성물
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4900685A (en) * 1987-01-29 1990-02-13 Cytosignet, Inc. Analyte detection in particulate-containing samples
US5494800A (en) * 1987-01-29 1996-02-27 Cytosignet, Inc. Analyte detection in particulate-containing samples
US5210040A (en) * 1987-07-29 1993-05-11 Abbott Laboratories Process for coupling antibodies or antibody fragments to liposomes
US5258499A (en) * 1988-05-16 1993-11-02 Vestar, Inc. Liposome targeting using receptor specific ligands
US5167925A (en) * 1988-06-08 1992-12-01 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5112770A (en) * 1988-06-08 1992-05-12 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
JPH0720857B2 (ja) * 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
US5139803A (en) * 1989-02-09 1992-08-18 Nabisco, Inc. Method and liposome composition for the stabilization of oxidizable substances
US5015483A (en) * 1989-02-09 1991-05-14 Nabisco Brands, Inc. Liposome composition for the stabilization of oxidizable substances
FR2657885A1 (fr) * 1990-02-08 1991-08-09 Cird Anticorps capables de reconnaitre specifiquement un antigene du stratum corneum de l'epiderme humain, leur preparation et leur application, notamme comme vecteurs de drogues.
FR2673179B1 (fr) * 1991-02-21 1993-06-11 Oreal Ceramides, leur procede de preparation et leurs applications en cosmetique et en dermopharmacie.
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (it) * 1992-07-16 1995-11-01 Kirin Brewery
AU683026B2 (en) * 1992-10-22 1997-10-30 Kirin Pharma Kabushiki Kaisha Novel shingoglycolipid and use thereof
JP2711974B2 (ja) * 1993-02-03 1998-02-10 日水製薬株式会社 免疫凝集反応試薬及び免疫分析方法
EP0694558B1 (en) * 1993-04-15 1999-01-27 Kirin Beer Kabushiki Kaisha Novel sphingoglycolipid and use thereof
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5705385A (en) * 1995-06-07 1998-01-06 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5981501A (en) * 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
US5976567A (en) * 1995-06-07 1999-11-02 Inex Pharmaceuticals Corp. Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
FI102922B (fi) * 1996-06-28 1999-03-15 Valtion Teknillinen Fluoresenssiin perustuva immunomääritysmenetelmä
AU733310C (en) 1997-05-14 2001-11-29 University Of British Columbia, The High efficiency encapsulation of charged therapeutic agents in lipid vesicles
US6136301A (en) * 1997-05-30 2000-10-24 E-L Management Corp. Lipid mix for lip product
FR2770523B1 (fr) 1997-11-04 1999-12-31 Oreal Compose de type ceramide, procede de preparation et utilisation
FR2775977B1 (fr) 1998-03-10 2000-06-23 Oreal Composes lipidiques derives des bases sphingoides, leur procede de preparation et leurs utilisations en cosmetique et en dermopharmacie
US20030072794A1 (en) * 2000-06-09 2003-04-17 Teni Boulikas Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
WO2002087541A1 (en) * 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Lipid-based formulations for gene transfer
EP1441763A2 (en) * 2001-11-07 2004-08-04 Inex Pharmaceuticals Corp. Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
FR2836042B1 (fr) 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
US20040009944A1 (en) * 2002-05-10 2004-01-15 Inex Pharmaceuticals Corporation Methylated immunostimulatory oligonucleotides and methods of using the same
US6790632B2 (en) * 2002-06-17 2004-09-14 Stephen Eliot Zweig Membrane receptor reagent and assay
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
FR2843963B1 (fr) 2002-08-30 2004-10-22 Sederma Sa Nouvelles molecules derivees de la noraporphine
US20040171522A1 (en) * 2003-02-27 2004-09-02 Yaron Ilan Regulation of immune responses by manipulation of intermediary metabolite levels
WO2005032462A2 (en) 2003-02-27 2005-04-14 Enzo Therapeutics, Inc. Glucocerebroside treatment of disease
US9717754B2 (en) 2003-02-27 2017-08-01 Enzo Therapeutics, Inc. Glucocerebroside treatment of disease
CA2532228C (en) * 2003-07-16 2017-02-14 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
EP1664316B1 (en) * 2003-09-15 2012-08-29 Protiva Biotherapeutics Inc. Polyethyleneglycol-modified lipid compounds and uses thereof
CA2542099A1 (en) * 2003-10-11 2005-04-21 Inex Pharmaceuticals Corporation Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
US7678540B2 (en) * 2003-10-16 2010-03-16 University Of Massachusetts Template-directed assembly of receptor signaling complexes
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
JP4764426B2 (ja) 2004-06-07 2011-09-07 プロチバ バイオセラピューティクス インコーポレイティッド カチオン性脂質および使用方法
FI20040825A0 (fi) * 2004-06-15 2004-06-15 Ani Biotech Oy Suodatinväline, sen käyttö, menetelmä ja kitti
EP1773857A4 (en) * 2004-07-02 2009-05-13 Protiva Biotherapeutics Inc THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
US20060051405A1 (en) * 2004-07-19 2006-03-09 Protiva Biotherapeutics, Inc. Compositions for the delivery of therapeutic agents and uses thereof
CA2587411A1 (en) * 2004-11-17 2006-05-26 Protiva Biotherapeutics, Inc. Sirna silencing of apolipoprotein b
US20070054873A1 (en) * 2005-08-26 2007-03-08 Protiva Biotherapeutics, Inc. Glucocorticoid modulation of nucleic acid-mediated immune stimulation
CN101346393B (zh) * 2005-11-02 2015-07-22 普洛体维生物治疗公司 修饰的siRNA分子及其应用
US7915399B2 (en) * 2006-06-09 2011-03-29 Protiva Biotherapeutics, Inc. Modified siRNA molecules and uses thereof
WO2008002656A2 (en) * 2006-06-28 2008-01-03 P.A. Technologies Llc Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
CA2721333C (en) 2008-04-15 2020-12-01 Protiva Biotherapeutics, Inc. Novel lipid formulations for nucleic acid delivery
CA2740000C (en) 2008-10-09 2017-12-12 Tekmira Pharmaceuticals Corporation Improved amino lipids and methods for the delivery of nucleic acids
WO2011000107A1 (en) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Novel lipid formulations for delivery of therapeutic agents to solid tumors
US9018187B2 (en) 2009-07-01 2015-04-28 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
US8569256B2 (en) 2009-07-01 2013-10-29 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
US9006417B2 (en) 2010-06-30 2015-04-14 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
EP4295895A3 (en) 2017-05-11 2024-03-27 Tc1 Llc Thermal interconnect for implantable blood pump
WO2022115645A1 (en) 2020-11-25 2022-06-02 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids, and related methods of use
CA3256897A1 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for the administration of nucleic acids and their methods of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887698A (en) * 1973-03-12 1975-06-03 Univ Leland Stanford Junior Sacs with epitopic sites on walls enclosing stable free radicals
US3850578A (en) * 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
JPS5341420A (en) * 1976-09-29 1978-04-14 Mochida Pharm Co Ltd Immunochemically measuring methoa of hapten
DE2650502C3 (de) * 1976-11-04 1980-01-17 Karl Dr.Med. 7302 Ostfildern Theurer Herstellung von Liposomen welche Arzneistoffe enthalten
US4195074A (en) * 1977-03-01 1980-03-25 Abbott Laboratories Process for producing a soluble rubella antigen
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4232001A (en) * 1978-09-22 1980-11-04 University Patents, Inc. Methods and materials for detection of estrophilin
DE3066899D1 (en) * 1979-01-18 1984-04-19 Unilever Plc Method for detecting and determining proteinaceous specific binding agents and materials bindable thereto, test composition and testkit therefor
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
JPS56132564A (en) * 1980-02-04 1981-10-16 Koraboreiteibu Research Inc Product for and method of immunity analysis
CA1165238A (en) * 1980-03-12 1984-04-10 Demetrios P. Papahadjopoulos Activated liposomes and method
AU543007B2 (en) * 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay
CA1166957A (en) * 1980-05-08 1984-05-08 Barry I. Bluestein Immunoassay for oncofetal antigen carried by lymphocytes
JPS5842971A (ja) * 1981-09-07 1983-03-12 Fuji Photo Film Co Ltd 抗体を感作させたマイクロカプセルを用いる細胞性免疫測定法

Also Published As

Publication number Publication date
CA1198053A (en) 1985-12-17
IT1149111B (it) 1986-12-03
WO1983001571A1 (en) 1983-05-11
EP0091958A1 (en) 1983-10-26
JPS58501819A (ja) 1983-10-27
EP0091958A4 (en) 1984-03-26
US4598051A (en) 1986-07-01

Similar Documents

Publication Publication Date Title
IT8249401A0 (it) Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici
ES523723A0 (es) Procedimiento de analisis inmunologico.
IT8121122A0 (it) Metodo di determinazione immunologica.
IT1208161B (it) Contenitore per prova di campioni.
IT8247814A0 (it) Reagente per saggio immunologico emetodo per effettuare il saggio
FI844017A7 (fi) Bioluminesenssiä hyväksi käyttävä immunologinen pitoisuusmääritys.
NO831986L (no) Glukosebestemmende analytisk element
ES506017A0 (es) Metodo para la determinacion de un analito biologico de interes utilizando agentes pluorescentes encapsulados.
IT8124162A0 (it) Metodo immunoenzimatico competitivo per la determinazione di antigeni.
NO822853L (no) Antigenbestemmelse.
DK234785A (da) Immunanalyse for serumantistoffer
IT8222140A0 (it) Procedimento senza centrifugazione per prova immunologica dimateriali.
DE3878077D1 (de) Immunologische messmethode.
FI863531A0 (fi) Immunobestaemningsfoerfarande foer en makromolekylaer analyt.
IL64574A (en) Method for determining the presence of an analyte by determination of the amount of fluorescence in competitive protein binding assays
FI854627A7 (fi) Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi.
FI871174A7 (fi) Menetelmä hapteenien määrittämiseksi immunoanalyysitekniikalla.
ES522186A0 (es) Metodo de ensayo de anticuerpos.
DE3482947D1 (de) Musterinspektion.
DE3586808D1 (de) L-thyroxin erkennende monoklonale antikoerper.
DK437087D0 (da) Monoklont antistof til bestemmelse af humant glycoalbumin
IT8319304A0 (it) Metodo di analisi altamente sensibile.
ES514387A0 (es) "metodo para la determinacion de las proteinas glicosiladas presentes en fluidos biologicos".
DE3483151D1 (de) Temperaturmessprobe.
IT8223974A0 (it) Reattivo per la determinazione delle beta-lipoproteine.